Literature DB >> 2065824

Neurodevelopmental therapy and upper-extremity inhibitive casting for children with cerebral palsy.

M Law1, D Cadman, P Rosenbaum, S Walter, D Russell, C DeMatteo.   

Abstract

The purpose of this research was to study the effect of intensive neurodevelopmental therapy (NDT) and upper-extremity inhibitive casting, separately or in combination, on hand function, quality of upper-extremity movement and range of motion of 73 children with spastic cerebral palsy aged 18 months to eight years. There was no significant difference between intensive or regular therapy and casting or no casting for hand function, between intensive and regular NDT, or between intensive NDT plus casting and the other groups for quality of movement and range of motion. Casting led to increased quality of movement and wrist extension after six months. Casting with NDT improved the quality of upper-extremity movement and range of motion. There appear to be no immediate benefits from intensive therapy alone.

Entities:  

Mesh:

Year:  1991        PMID: 2065824     DOI: 10.1111/j.1469-8749.1991.tb14897.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  14 in total

1.  Toronto clinic's new approach.

Authors:  P Rosenbaum; C Gowland; G King; S King; M Law; D Russell; A Willan
Journal:  CMAJ       Date:  1993-04-15       Impact factor: 8.262

2.  LEARN 2 MOVE 2-3: a randomized controlled trial on the efficacy of child-focused intervention and context-focused intervention in preschool children with cerebral palsy.

Authors:  Marjolijn Ketelaar; Anne J A Kruijsen; Olaf Verschuren; Marian J Jongmans; Jan Willem Gorter; Johannes Verheijden; Heleen A Reinders-Messelink; Eline Lindeman
Journal:  BMC Pediatr       Date:  2010-11-08       Impact factor: 2.125

3.  MRI predicts efficacy of constraint-induced movement therapy in children with brain injury.

Authors:  Maria A Rocca; Anna C Turconi; Sandra Strazzer; Martina Absinta; Paola Valsasina; Elena Beretta; Massimiliano Copetti; Monica Cazzagon; Andrea Falini; Massimo Filippi
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

4.  Feasibility and effectiveness of home-based therapy programmes for children with cerebral palsy: a systematic review.

Authors:  Laura W M E Beckers; Mellanie M E Geijen; Jos Kleijnen; Eugene A A Rameckers; Marlous L A P Schnackers; Rob J E M Smeets; Yvonne J M Janssen-Potten
Journal:  BMJ Open       Date:  2020-10-06       Impact factor: 2.692

Review 5.  Nonoperative management of spasticity in children.

Authors:  Susan Ronan; Joan T Gold
Journal:  Childs Nerv Syst       Date:  2007-07-24       Impact factor: 1.475

6.  Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.

Authors:  Megan Thorley; Samantha Donaghey; Priya Edwards; Lisa Copeland; Megan Kentish; Kim McLennan; Jayne Lindsley; Laura Gascoigne-Pees; Leanne Sakzewski; Roslyn N Boyd
Journal:  BMC Pediatr       Date:  2012-08-09       Impact factor: 2.125

Review 7.  Stretch for the treatment and prevention of contractures.

Authors:  Lisa A Harvey; Owen M Katalinic; Robert D Herbert; Anne M Moseley; Natasha A Lannin; Karl Schurr
Journal:  Cochrane Database Syst Rev       Date:  2017-01-09

8.  Modified constraint-induced movement therapy or bimanual occupational therapy following injection of Botulinum toxin-A to improve bimanual performance in young children with hemiplegic cerebral palsy: a randomised controlled trial methods paper.

Authors:  Brian J Hoare; Christine Imms; Hyam Barry Rawicki; Leeanne Carey
Journal:  BMC Neurol       Date:  2010-07-05       Impact factor: 2.474

9.  Upper extremity constraint-induced movement therapy in infantile hemiplegia.

Authors:  Selvam Ramachandran; Preeti Thakur
Journal:  J Pediatr Neurosci       Date:  2011-01

Review 10.  Effectiveness of physical therapy interventions for children with cerebral palsy: a systematic review.

Authors:  Heidi Anttila; Ilona Autti-Rämö; Jutta Suoranta; Marjukka Mäkelä; Antti Malmivaara
Journal:  BMC Pediatr       Date:  2008-04-24       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.